Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02217280 · ClinicalTrials.gov registry record · NA
Dispersal Pattern for Spine Injections (Gadolinium Contrast)
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02217280 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 20 participants.
The verdict
NCT02217280, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study will analyze injectate dispersal patterns after standard-of-care cervical epidural steroid injections using gadolinium as a marker and magnetic resonance imaging (MRI) to characterize the pattern. Although these procedures are performed with high frequency under the assumption that injectate remains localized to injection site, no peer-reviewed studies have validated this assumption. Comprehensive characterization of injectate dispersal patterns will provide important data regarding safety, as well as diagnostic and therapeutic potential of cervical epidural steroid injections.
Interventions
- DRUG Injection with Gadolinium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02217280
The ClinicalTrials.gov registry entry for NCT02217280 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Injection with Gadolinium is the first listed.
NCT02217280 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02217280 about?
NCT02217280 is a clinical study titled "Dispersal Pattern for Spine Injections (Gadolinium Contrast)". This study will analyze injectate dispersal patterns after standard-of-care cervical epidural steroid injections using gadolinium as a marker and magnetic resonance imaging (MRI) to characterize the pattern. Although these procedures are performed with high frequency under the assumption that inject...
What is the current status of trial NCT02217280?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2015-04. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02217280?
The interventions under investigation include: Injection with Gadolinium (DRUG).
Who is sponsoring clinical trial NCT02217280?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.